|
FDA Drug Safety Science ‘Evolving,’ Wireless Reporting Future Eyed: CDER
While CDER is improving its drug safety efforts by giving equal weight to pre- and postmarket analysis, the center’s safety science is still evolving and may potentially include wireless technologies to transmit point-of-care data, a new FDA report states.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives